| Name | Title | Contact Details |
|---|
ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III
MediTech Media, Ltd is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
The Centers for Medicare & Medicaid Services (CMS), a federal agency within the U.S. Department of Health and Human Services, is one of the largest purchasers of health care in the world. Medicare, Medicaid, and the Childrens Health Insurance Program (CHIP) provide health care for one in four Americans.
Kelley X-Ray Co is a Chattanooga, TN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Vascular Solutions, Inc. (Vascular), incorporated in December 1996, is a medical device company focused on bringing clinically advanced solutions to interventional cardiologists and interventional radiologists worldwide.